HIV & Liver Disease 2025 Conference

Thursday, September 25, 2025, 4:00 PM - Saturday, September 27, 2025, 1:15 PM, Jackson Lake Lodge 101 Jackson Lake Lodge Rd.

AMA PRA Category 1 Credits™ (11.50 hours), AMA PRA Category 1 Credits™ Designated (11.50 hours)


Liver disease is a major cause of morbidity and mortality in people living with HIV and are a result of factors such as viral hepatitis, metabolic perturbations, and substance use. This conference addresses the increasingly prevalent clinical issues and challenges associated with HIV and liver disease. It brings together internationally renowned experts and clinicians, including hepatology and infectious diseases, to discuss the most current and clinically relevant info pertinent to improving patient outcomes.

This activity is limited to a specific target audience; however, special considerations may be made.
For special considerations or additional information, please contact Conference & Event Services at [email protected] or 513-558-1810

Registration Fees for the 2024 Conference are as follows:

$300 - MD, DO, PhD
$125 - RHP, PA, RN
$75 - Trainee (Fellow, Resident, Medical Student) 


For more information and to register, please visit hivandliverdisease.com

1. Review the epidemiology of HIV infection and liver disease in patients with HIV and liver disease
2. Discuss current treatment guidelines for the management of patients with HIV and viral hepatitis coinfection (HBV and HCV)
3. Explain issues of aging of the liver and other organs in the setting of HIV
4. Explain the pathogenesis of liver injury & disease progression in patients with HIV
5. Describe the effect of alcohol on liver injury and ways to reduce harm from alcohol and other substances
6. Report on the drugs currently used and to be used for the treatment of viral hepatitis
7. Analyze the progression of decompensatcd liver and HCC and the role of liver transplantation in those with HIV and liver disease
8. Assess the risk of antiretroviral therapy (ART) injury in patients with ESLD
9. Summarize the psychiatric difficulties that can develop in patients with HIV and liver disease
10. Examine treatment outcomes in injection drug users with or at risk for HIV and liver disease

Accreditation & Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the University of California, San Francisco. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Cincinnati designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

 The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.

The conference will be held at Jackson Lake Lodge, Moran, Wyoming 83013.  For information on Jackson Lake Lodge, please visit www.gtlc.com/lodges/jackson-lake-lodge

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

No faculty are available for this activity at this time.